This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Signum Dermalogix Partners With Elizabeth Arden, Launches Product Containing Cosmetic Functional Ingredient Arazine™

PRINCETON, N.J., Feb. 26, 2013 /PRNewswire/ -- Signum Dermalogix Inc., a private biopharmaceutical company focused on developing new and innovative dermatological products and services has entered into a partnership with Elizabeth Arden, Inc. focusing on a semi-exclusive global license for the cosmetic functional ingredient Arazine™ (N-acetyl-S-farnesyl-cysteine) as well as developing new screening methodologies to measure the anti-oxidant potential of Arden's other product ingredients.

Arazine™, initially discovered at Princeton University possesses anti-inflammatory and anti-oxidant properties making it an ideal complement with Idebenone-ester as key ingredients in Elizabeth Arden's Prevage® Anti-aging + Intensive Repair Daily Serum product.

Arazine™ is the first cosmetic ingredient from Signum Dermalogix's novel technology platform to be commercialized. Maxwell Stock, CEO of Signum Dermalogix commented, "We are excited about our partnership with Arden especially given their commitment to bringing a scientific approach to developing new and innovative skin care products. We believe this is just the beginning of a dynamic collaboration that will enable the development of a first in class line of skin care products."

Dr. Eduardo Perez, VP of R&D stated, "With Elizabeth Arden's decades of experience in skin care and our R&D and chemical expertise, we look forward to assisting Elizabeth Arden's efforts in producing innovative, high quality skin care products supported with robust scientific data."

Given the successful launch of Arazine™ in the Prevage® line, Signum Dermalogix is now focused on developing a second generation of novel cosmetic ingredients as well as finding a partner to commercialize Arazine™ in the physician dispensed channel.

About Signum DermalogixSignum Dermalogix was founded in 2011 and is a spin‐out of Signum Biosciences. Signum Dermalogix is a dermatology focused company developing novel cosmetic ingredients and drug compounds. Signum Dermalogix also provides dermatology testing, custom assay development and analytical services. For more information please visit: www.signumdermalogix.com.

About Elizabeth Arden Elizabeth Arden is a global prestige beauty products company with an extensive portfolio of prestige beauty brands sold in over 100 countries. The company's brand portfolio includes Elizabeth Arden skincare, color, and fragrance products, PREVAGE® anti-aging formulas, the celebrity fragrance brands of Britney Spears, Elizabeth Taylor, Mariah Carey, Taylor Swift, and Usher; the designer fragrance brands of Juicy Couture, Alberta Ferretti, Alfred Sung, Badgley Mischka, Bob Mackie, Geoffrey Beene, Halston, John Varvatos, Kate Spade, Lucky Brand, and Rocawear; and the lifestyle fragrance brands Curve, Giorgio Beverly Hills, and PS Fine Cologne.

 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,002.07 -68.33 -0.38%
S&P 500 2,100.72 -13.77 -0.65%
NASDAQ 4,961.6030 -55.3260 -1.10%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs